Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Phage-dependent modulation of Streptococcus thermophilus on ß- galactosidase effects on colorectal tumors.

EF 2023-24

Résumé
Colorectal cancer (CRC) is leading cause of death worldwide. It is imperative to implement preventative and therapeutic strategies. CRC is accompanied by alteration in the intestinal microbiota. Recently, the administration of Streptococcus thermophilus, a lactic acid bacterium utilized in the production of fermented milk products, was shown to display anti-colorectal cancer properties depending on the anti-proliferative activity of its released enzyme ß-galactosidase. In the colon, this enzyme releases galactose from lactose-containing substrates and affects oncogenic pathways. Though, while all S. thermophilus strains express ß-galactosidase, only the ATCC 19258 strain was found to be effective in the context of CRC. The ATCC 19258 strain possesses a lysogenic bacteriophage (?20617) responsible for conferring fragility to its cell wall. This is a unique trait of this strain. The objective of this study is to determine if the presence of the ?20617 phage increases the secretion of ß-galactosidase from the bacteria cell thereby influencing the anti-colon cancer effects of S. thermophilus. This will be assessed using a mouse model of intestinal tumorigenesis. Mice will be gavaged with live cells of the ATCC 19258 strain or its phage-free derivative and will receive a diet with or without lactose to assess its importance for the bacterium effects. Number and size of colorectal tumors will be assessed after 14 weeks. Fecal ß-galactosidase activity and abundance of S. thermophilus will also be measured. We anticipate that the phage will facilitate the anti-cancer effects of its bacterium host and that dietary lactose is necessary for these benefits. These findings will provide a mechanistic understanding of the effects of S. thermophilus in the context of colorectal cancer.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
506000
Name
Dimoff Zoe K
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Phage-dependent modulation of Streptococcus thermophilus on ß- galactosidase effects on colorectal tumors.
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Anti-Cancer; Bacteriophage; Colorectal Cancer; Dysbiosis; Galactose; Lactose; Mice; Microbiota; Streptococcus Thermophilus; ß-Galactosidase
Abstract
Colorectal cancer (CRC) is leading cause of death worldwide. It is imperative to implement preventative and therapeutic strategies. CRC is accompanied by alteration in the intestinal microbiota. Recently, the administration of Streptococcus thermophilus, a lactic acid bacterium utilized in the production of fermented milk products, was shown to display anti-colorectal cancer properties depending on the anti-proliferative activity of its released enzyme ß-galactosidase. In the colon, this enzyme releases galactose from lactose-containing substrates and affects oncogenic pathways. Though, while all S. thermophilus strains express ß-galactosidase, only the ATCC 19258 strain was found to be effective in the context of CRC. The ATCC 19258 strain possesses a lysogenic bacteriophage (?20617) responsible for conferring fragility to its cell wall. This is a unique trait of this strain. The objective of this study is to determine if the presence of the ?20617 phage increases the secretion of ß-galactosidase from the bacteria cell thereby influencing the anti-colon cancer effects of S. thermophilus. This will be assessed using a mouse model of intestinal tumorigenesis. Mice will be gavaged with live cells of the ATCC 19258 strain or its phage-free derivative and will receive a diet with or without lactose to assess its importance for the bacterium effects. Number and size of colorectal tumors will be assessed after 14 weeks. Fecal ß-galactosidase activity and abundance of S. thermophilus will also be measured. We anticipate that the phage will facilitate the anti-cancer effects of its bacterium host and that dietary lactose is necessary for these benefits. These findings will provide a mechanistic understanding of the effects of S. thermophilus in the context of colorectal cancer.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Dimoff, Zoe K
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~